Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to -$2.6 billion.

  • Sanofi's Asset Writedowns and Impairment fell 45612.55% to -$2.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.1 billion, marking a year-over-year decrease of 106474.63%. This contributed to the annual value of -$2.5 billion for FY2025, which is 84350.65% down from last year.
  • Sanofi's Asset Writedowns and Impairment amounted to -$2.6 billion in Q4 2025, which was down 45612.55% from -$266.5 million recorded in Q3 2025.
  • Sanofi's 5-year Asset Writedowns and Impairment high stood at $463.2 million for Q4 2022, and its period low was -$2.6 billion during Q4 2025.
  • In the last 5 years, Sanofi's Asset Writedowns and Impairment had a median value of -$87.5 million in 2022 and averaged -$317.1 million.
  • Over the last 5 years, Sanofi's Asset Writedowns and Impairment had its largest YoY gain of 31088.47% in 2022, and its largest YoY loss of 13570079.83% in 2022.
  • Sanofi's Asset Writedowns and Impairment (Quarter) stood at -$219.6 million in 2021, then skyrocketed by 310.88% to $463.2 million in 2022, then tumbled by 308.13% to -$964.0 million in 2023, then soared by 51.34% to -$469.1 million in 2024, then tumbled by 456.13% to -$2.6 billion in 2025.
  • Its Asset Writedowns and Impairment was -$2.6 billion in Q4 2025, compared to -$266.5 million in Q3 2025 and -$209.4 million in Q2 2025.